oxonic acid has been researched along with Recrudescence in 119 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prognostic factors for patients with relapse and unresectable biliary tract cancer, treated with Tegafur Gimeracil Oteracil Potassium (S-1) after failure of gemcitabine (GEM), are unclear." | 8.12 | [Evaluation of Prognostic Factors in Patients with Relapse and Unresectable Biliary Tract Cancer, Treated with S-1 after Failure of Gemcitabine]. ( Funahara, H; Hiraki, K; Kikkawa, A; Matsumoto, S; Nakai, M, 2022) |
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 7.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/week (day 1), 5-fluorouracil 500 mg/day (days 1-5), cisplatin 10 mg/day (days 1-5)." | 5.33 | A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. ( Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T, 2006) |
| "Prognostic factors for patients with relapse and unresectable biliary tract cancer, treated with Tegafur Gimeracil Oteracil Potassium (S-1) after failure of gemcitabine (GEM), are unclear." | 4.12 | [Evaluation of Prognostic Factors in Patients with Relapse and Unresectable Biliary Tract Cancer, Treated with S-1 after Failure of Gemcitabine]. ( Funahara, H; Hiraki, K; Kikkawa, A; Matsumoto, S; Nakai, M, 2022) |
| "S-1, an oral 5-fluorouracil (5-FU)-based medicine that combines tegafur, gimeracil and oteracil potassium is commonly used as an adjuvant chemotherapeutic drug for the treatment of colorectal cancer." | 3.83 | Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy. ( Kokuryo, T; Nagino, M; Uehara, K; Yamaguchi, J; Yamauchi, K; Yokoyama, Y, 2016) |
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 3.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "Patients with recurrent or metastatic gastric cancer diagnosed by pathology were randomly divided into two groups to receive six cycles of either the TIROX regimen (21-day cycle) or the DCF regimen (21-day cycle)." | 2.79 | Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. ( Chang, ZW; Dong, L; Han, ZF; Li, J; Lou, XP; Lu, P; Miao, JH, 2014) |
| "This phase II study of S-1 in cervical cancer suggests a promising response rate and a contribution toward prolonging survival, with modest toxic effects." | 2.76 | Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer. ( Hatae, M; Hirai, Y; Kamiura, S; Katsumata, N; Kokawa, K; Nishimura, R; Ochiai, K; Sugiyama, T, 2011) |
| "Standard chemotherapy for advanced gastric cancer was changed to S-1/CDDP by SPIRITS phase III trial which was presented just after this trial was initiated, which would be a major cause of slow accrual." | 2.76 | [Randomized phase II trial to compare S-1 and S-1/PSK for advanced or recurrent gastric cancer-lessons from the results]. ( Aoyama, T; Hasegawa, S; Kanemoto, A; Saze, Z; Tahara, H; Terashima, M; Tsuburaya, A; Yoshikawa, T, 2011) |
| "S-1 showed clinical activity in colorectal cancer, and the preclinical data of S-1 with oxaliplatin showed synergistic activity in an animal model." | 2.74 | A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer. ( Kang, EM; Kang, WK; Kim, HS; Lee, HY; Lee, J; Lee, Y; Lim, HY; Park, JO; Park, MJ; Park, SH; Park, YS; Uhm, JE, 2009) |
| "Biliary tract cancers are among the most aggressive tumors with a poor prognosis." | 2.73 | Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer. ( Kang, JH; Kim, HG; Kim, HJ; Kim, TH; Lee, GW; Oh, SY, 2008) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "Nearly 70% of gastric cancer recurrences occur as peritoneal dissemination." | 2.55 | [A Case of QOL Improvement after Intestinal Stenosis Due to Peritoneal Dissemination of Gastric Cancer in Elderly Patients]. ( Furuke, Y; Ikeda, J; Imura, K; Komatsu, S; Kumano, T; Nakatsugawa, Y; Shimomura, K; Shioaki, Y; Tanaka, Y; Taniguchi, F, 2017) |
| "An 80-year-old man with a local recurrence of gastric cancer was treated with S-1 monotherapy leading to a complete response(CR)." | 2.53 | [An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy]. ( Hasegawa, M; Ichikawa, K; Kokado, Y; Koshiba, T; Kusama, T; Sone, N; Yamagami, K, 2016) |
| "We report a case of P0CY1 gastric cancer that is successfullytreated with gastrectomyand S-1/Lentinan combined chemotherapyand has not recurred for long time postoperatively." | 1.48 | [A Case of P0CY1 Gastric Cancer without Recurrence for 13 Years Postoperatively]. ( Cho, H; Okamoto, S, 2018) |
| "There was no recurrence for more than 2 years after the lung surgery." | 1.46 | [A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period]. ( Ikeda, H; Kakegawa, S; Matsumoto, I; Saito, D; Takata, M; Takemura, H; Tamura, M; Tanaka, Y; Yoshida, S, 2017) |
| "It has been suggested that port site recurrence is a potential complication after laparoscopic distal gastrectomy for gastric cancer, especially considering the increased number of laparoscopic surgeries being performed." | 1.43 | [A Case of Port Site Recurrence after Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer]. ( Chida, S; Fujita, S; Hayase, S; Kase, K; Kono, K; Monma, T; Ohki, S; Ohtake, T; Sakamoto, W; Takawa, M; Takenoshita, S; Yamauchi, N, 2016) |
| "The mean recurrence-free survival was 13." | 1.43 | [Adjuvant Systemic Chemotherapy with S-1/Oxaliplatin or mFOLFOX6 after Curative Resection of Distant Metastases in Patients with Colorectal Cancer]. ( Amada, E; Baba, S; Kameyama, N; Mitsuhashi, H; Miyata, R; Tomita, M, 2016) |
| "A 57-year-old man with advanced gastric cancer and multiple liver metastases was referred to our hospital." | 1.43 | [A Case of Advanced Gastric Cancer with Portosystemic Shunt Successfully Treated with Percutaneous Transvenous Coil Embolization]. ( Hanyu, T; Hishiki, M; Ichikawa, H; Ishikawa, T; Kameyama, H; Kano, Y; Kobayashi, T; Kosugi, S; Muneoka, Y; Nagahashi, M; Otani, T; Sakata, J; Sato, Y; Usui, K; Wakai, T, 2016) |
| "Virchow's lymph node metastasis was confirmed 2 months after surgery." | 1.43 | [A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)]. ( Kabashima, A; Maekawa, S; Sanefuji, K; Tanaka, S, 2016) |
| "A 62-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy, and D1+b lymph node dissection." | 1.42 | [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)]. ( Hosoda, Y; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T; Yamasaki, M; Yasui, M, 2015) |
| "The patient had no recurrence for 1 year after the last surgery." | 1.42 | [A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer]. ( Arai, S; Kataoka, M; Miyazawa, K; Oeda, Y; Shiobara, M; Suda, K; Takagi, T; Wakatsuki, K; Yoshioka, S, 2015) |
| "When tumor recurrence was found by MRI 30 months later, an additional liver resection was planned but a laparotomy was eventually performed." | 1.42 | [Six-year survival with recurrent intrahepatic cholangiocarcinoma achieved by simple S-1 administration]. ( Hirose, T; Ishikawa, Y; Kitamura, K; Miki, A; Minami, T; Morioka, H; Nishihira, T; Otani, T; Suzuki, T; Yoshitani, S, 2015) |
| "An abdominal CT demonstrated local recurrence at the hepatoduodenal ligament." | 1.42 | [A Case of Local Recurrence of Bile Duct Cancer Completely Responding to Chemoradiotherapy with S-1]. ( Hishikawa, H; Matsuura, T; Ozaki, T; Saito, T; Sakaguchi, T; Sueyoshi, H; Tanaka, Y; Ueda, A; Yamamichi, K, 2015) |
| "A 64-year-old man was diagnosed with pancreatic cancer by abdominal computed tomography (CT)." | 1.42 | [A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
| "She died from gastric cancer in December 2012." | 1.42 | [A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]. ( Hamakawa, T; Hoshino, H; Ikeda, N; Kamigaki, S; Kawase, T; Kimura, Y; Makari, Y; Mikami, J; Munakata, S; Nakata, K; Ohzato, H; Tsujie, M; Yamamoto, T; Yamamura, J, 2015) |
| "Metastatic recurrence occurred on the transverse colon, for which she underwent transverse colectomy 2." | 1.42 | [A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy]. ( Fujii, Y; Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Miura, S; Morioka, E; Nakano, Y; Noguchi, M; Ohonishi, T; Ohono, Y; Sakata, N; Tomita, Y; Ueda, N, 2015) |
| "He developed peritoneal recurrence with serum tumor marker elevation in May 2014." | 1.42 | [A Case of Rectal Stenosis For Gastric Cancer Recurrence Effectively Treated with a Colonic Stent]. ( Ebihara, K; Fujimori, M; Gobaru, A; Hamakawa, T; Kato, F; Kawase, T; Kimura, Y; Kitamura, S; Makari, Y; Mikami, J; Mitsudo, D; Nakata, K; Ohzato, H; Tsujie, M; Tsukamoto, Y; Yabuta, T, 2015) |
| "Abdominal computed tomography showed gastric cancer invasion to the left liver lobe." | 1.42 | [A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy]. ( Kawamoto, S; Maeno, H; Munechika, T; Nagao, S; Nomi, M; Okamoto, T; Sasaguri, T; Sueishi, K; Tanaka, K; Yonemitsu, K, 2015) |
| "A gastric cancer recurrence with paraaortic lymph node (PALN) metastasis was diagnosed fifteen months after the operation." | 1.40 | [A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. ( Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2014) |
| "An autopsy showed the recurrence lesions had diffusely spread to the peritoneum and was also disseminated around the Roux-Y jejunum." | 1.40 | [A case of resection margin involvement gastric carcinoma that relapsed late after additional gastrectomy]. ( Asaoka, T; Fukuda, Y; Harada, Y; Haraguchi, N; Hirao, M; Ikeda, M; Kanzawa, M; Kodama, Y; Maeda, S; Mano, M; Miyake, M; Miyamoto, A; Nakamori, S; Nishikawa, K; Omiya, H; Sekimoto, M; Takami, K; Yamamoto, K, 2014) |
| "A 55-year-old man suffering from gastric cancer associated with metastases to the lymph node, gallbladder, and liver was administered chemotherapy with S-1 and cisplatin." | 1.40 | [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. ( Akiyama, Y; Hasuike, Y; Higuchi, I; Miyamoto, M; Tanigawa, T; Yamamoto, M, 2014) |
| "We identified a case of gastric cancer showing response to first-line capecitabine/CDDP therapy after lymph node recurrence following the administration of S-1 as postoperative adjuvant chemotherapy." | 1.40 | [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy]. ( Egawa, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Nishiya, S; Yamashiro, N, 2014) |
| "Although there was no progression of gastric cancer, medication of S-1 was discontinued." | 1.40 | [Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer]. ( Fujisaki, S; Sakurai, K; Takashina, M; Takayama, T; Tomita, R, 2014) |
| "The patient died from recurrence of gastric cancer 69 months after completion of the initial chemotherapy and 2 months after the stent insertion." | 1.40 | [Effectiveness of chemoradiotherapy for a patient with local recurrence of advanced gastric cancer followed by curable gastrectomy]. ( Ishiyama, S; Iwasaki, Y; Maeda, Y; Natsume, S; Oohinata, R; Takahashi, K; Yajima, K; Yuu, K, 2014) |
| " However, he experienced adverse effects, and subsequently, he was effectively treated with cisplatin (CDDP) and irinotecan (CPT-11)." | 1.39 | [An effective treatment by chemotherapy with CDDP+CPT-11 for recurrent gastric cancer which S-1 cannot be used owing to adverse effects]. ( Aoyagi, H; Hasegawa, K; Isogai, J; Kaneko, J; Maejima, S; Matsui, T; Yoshida, T, 2013) |
| "Two patients survived without recurrence for 12 and 21 months." | 1.39 | [Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer]. ( Hasuike, Y; Hirao, S; Ishida, K; Iwagami, Y; Koshino, T; Tomoda, K; Toyomasu, T; Yoshikawa, S, 2013) |
| "A case of recurrent pancreatic cancer effectively responded to S-1 and irinotecan combined with third-line chemotherapy (IRIS) with PSK." | 1.39 | [A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK]. ( Asano, T; Ishii, M; Iwata, K; Kobayashi, H; Kobayashi, S; Koizumi, S; Okamura, R; Otsubo, T; Saji, O; Sumiyoshi, K, 2013) |
| "HER2-positive recurrent gastric cancer was characterized by a differentiated histological feature and frequent blood vessel invasion." | 1.39 | [Clinical significance of the human epidermal growth factor receptor 2( HER2) in patients with recurrent gastric cancer who received S-1 adjuvant chemotherapy]. ( Aoyama, T; Cho, H; Fujikawa, H; Hayashi, T; Kitani, Y; Masuda, M; Ogata, T; Oshima, T; Ozawa, Y; Rino, Y; Wada, H; Yoshikawa, T; Yukawa, N, 2013) |
| "He survived without recurrence for approximately 2 years after gastrectomy." | 1.39 | [A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel]. ( Ebisui, C; Fukuchi, N; Kato, R; Kinuta, M; Makino, S; Murata, K; Okada, K; Okamura, S; Takeoka, T; Wada, Y; Yanagisawa, T; Yokouchi, H, 2013) |
| "He is free of recurrence now without adjuvant chemotherapy four years after repeat hepatectomy." | 1.39 | [A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer]. ( Bando, E; Goto, H; Kawamura, T; Makuuchi, R; Miki, Y; Sugisawa, N; Tanizawa, Y; Terashima, M; Tokunaga, M; Uesaka, K; Yamakawa, Y, 2013) |
| "The patient has no signs of recurrence and has survived in fair condition for more than 5 years after the surgery." | 1.38 | [A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP]. ( Ikeda, T; Minamoto, K; Yuasa, I, 2012) |
| " When administering cancer chemotherapy to the elderly aged 70 and older, the patient's renal function, PS and Ccr, should be studied, and a regimen and dosage should be carefully selected." | 1.38 | [Tolerable evaluation for chemotherapy with S-1 plus cisplatin in elderly patients with advanced and recurrent gastric cancer]. ( Ito, D; Iwai, M; Kimura, M; Nakao, T; Okada, K; Usami, E; Yasuda, T; Yoshimura, T, 2012) |
| "The pathological diagnosis revealed squamous cell carcinoma of the left breast(pT3N1M0, Stage III A)." | 1.38 | [A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast]. ( Arihiro, K; Emi, A; Haruta, R; Kadoya, T; Kajitani, K; Kanno, E; Kataoka, T; Kobayashi, Y; Masumoto, N; Okada, M; Sasada, T; Shigematsu, H, 2012) |
| "Here, we present a case of recurrent gastric cancer that showed a partial response resulting in 6 months of progres-sion-free survival, thanks to capecitabine/CDDP after the failure of multiple anticancer drugs such as S-1/CDDP." | 1.38 | [A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP]. ( Adachi, T; Goto, A; Itoh, M; Kanno, S; Kondo, Y; Mitsuhashi, K; Shinomura, Y; Suzuki, T; Wakasugi, H; Yabana, T, 2012) |
| "The patient was diagnosed with hepatocellular carcinoma during work-up for hepatic dysfunction." | 1.38 | [A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2012) |
| "Since no obvious metastasis was recognized by abdominal computed tomography(CT), he underwent distal gastrectomy with D1+ lymphadenectomy." | 1.38 | [A case of early gastric cancer with cervical lymph nodes recurrence 5 years after a curative resection]. ( Amano, R; Hirakawa, K; Kimura, K; Kubo, N; Maeda, K; Muguruma, K; Nagahara, H; Noda, E; Ohira, M; Sakurai, K; Sawada, T; Tanaka, H, 2012) |
| "No distant recurrence was noted during this time." | 1.37 | [A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy]. ( Dan, N; Hori, T; Nishino, H; Tendo, M; Tezuka, K, 2011) |
| "We clinically analyzed 8 oral squamous cell carcinoma patients showing a complete response(CR)to chemotherapy with S-1 alone." | 1.37 | [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone]. ( Aoki, M; Iwamoto, O; Koga, C; Koga, M; Kusukawa, J; Nakamura, M, 2011) |
| "Nodal recurrence was resolved in 2 years after the start of treatment with S-1, and recurrence in the remnant liver nearly resolved in 4 years after starting the treatment, indicating a partial response." | 1.37 | [A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2011) |
| "A 60-year-old man with intrahepatic cholangiocarcinoma (ICC) underwent a left hepatectomy." | 1.37 | [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Ikeda, K; Iwazawa, T; Kawanishi, K; Kitada, M; Miyake, M; Nagai, K; Shimano, T; Shimizu, J, 2011) |
| "A 77-year-old man was diagnosed as hepatocellular carcinoma, and was referred to our hospital." | 1.37 | [A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. ( Doki, Y; Eguchi, H; Katsura, Y; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H; Wakasa, K, 2011) |
| "A case of a 68-year-old man with hepatocellular carcinoma (HCC) is presented." | 1.37 | [A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium]. ( Doki, Y; Eguchi, H; Kawamoto, K; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H, 2011) |
| "He was an HBV carrier, and hepatocellular carcinoma (HCC) was detected for the first time in 2000." | 1.37 | [Retroperitoneal metastasis of hepatocellular carcinoma - a case report]. ( Kameda, R; Kanazawa, A; Kobayashi, S; Miyakawa, K; Morinaga, S; Ohkawa, S; Tamura, S; Ueno, M; Yamamoto, N, 2011) |
| "He has been well without any sign of recurrence or elevation of tumor markers for 2 years." | 1.36 | [Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT]. ( Saito, T; Sasaki, H; Tokunaga, Y, 2010) |
| " In view of the side effects such as reduction in appetite and leukocyte, the dosage has been reduced as of the second course of treatment." | 1.36 | [A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy]. ( Fujikuni, N; Hashimoto, M; Iwako, H; Kuranishi, F; Kuroda, Y; Moriyuki, T; Niitsu, H, 2010) |
| "We herein report a case of recurrent gallbladder cancer with a remarkable tumor response to S-1 after a failure of gemcitabine (GEM) treatment." | 1.36 | [A case of recurrent gallbladder cancer with a remarkable tumor response to S-1]. ( Ajiki, T; Fujita, T; Ku, Y, 2010) |
| "Median survival time following recurrence was 287 days in cohort A, 451 days in B and 547 days in C, with a significant difference between A and C (p = 0." | 1.36 | Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer. ( Fujitani, K; Hasegawa, H; Hirao, M; Kurokawa, Y; Mita, E; Nakazuru, S; Tsujinaka, T, 2010) |
| " The urinary uracil value reflecting DPD activity of the whole body could be used as an index of recurrence at the time of long-term dosage of S-1." | 1.35 | [Study of a relationship between a change in the urinary uracil value after a S-1 long-term administration and the recurrence of stomach cancer]. ( Akiyama, I; Fujita, Y; Hasegawa, K; Morimoto, S; Shono, Y; Tabuse, K; Tsuji, T, 2008) |
| "The patient was recurrence-free and her clinical course was satisfactory." | 1.35 | [Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy]. ( Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T, 2008) |
| "/ Against metastases to orbital foramen, chest wall and bone, the oral treatment with S-1 was started at 80 mg/day everyday for 4 weeks, followed by a 2-week rest interval as 1 cycle, and ZOL was injected at 4 mg every 4 weeks." | 1.35 | [A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Arita, K; Hiranuma, S; Kuramochi, J; Kurokawa, T; Matsumoto, A; Sanada, K; Takiguchi, N; Tanaka, Y; Usui, S, 2009) |
| " Creatinine clearance of this patient calculated by Cockcroft-Gault method was 44 mL/min and renal function was impaired, so we reduced the administration dosage to 50 mg/day." | 1.35 | [A case of an older adult patient with recurrent gastric cancer successfully treated by low-dose S-1 for a long time]. ( Danno, K; Imaoka, S; Iwazawa, T; Kano, T; Kimura, Y; Miyazaki, S; Monden, T; Nakano, Y; Ohnishi, T; Tono, T; Yano, H, 2009) |
| "We report a case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy." | 1.35 | [A case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy]. ( Hara, Y; Kawano, T; Maekawa, K; Minami, Y; Ueda, S, 2009) |
| "Under the diagnosis of multiple lung metastases, the patient was hospitalized and received intensive chemotherapy with docetaxel 40 mg/week (day 1), 5-fluorouracil 500 mg/day (days 1-5), cisplatin 10 mg/day (days 1-5)." | 1.33 | A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. ( Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 23 (19.33) | 29.6817 |
| 2010's | 94 (78.99) | 24.3611 |
| 2020's | 2 (1.68) | 2.80 |
| Authors | Studies |
|---|---|
| Nakai, M | 1 |
| Kikkawa, A | 1 |
| Funahara, H | 1 |
| Matsumoto, S | 1 |
| Hiraki, K | 1 |
| Komatsu-Fujii, T | 1 |
| Ogawa, M | 2 |
| Nonoyama, S | 1 |
| Fukumoto, T | 2 |
| Tanabe, H | 1 |
| Toyokawa, T | 1 |
| Tamura, T | 1 |
| Shibutani, M | 1 |
| Ohira, G | 1 |
| Yamazoe, S | 1 |
| Kimura, K | 4 |
| Nagahara, H | 3 |
| Amano, R | 3 |
| Tanaka, H | 3 |
| Muguruma, K | 3 |
| Yashiro, M | 1 |
| Hirakawa, K | 3 |
| Ohira, M | 3 |
| Yoshizawa, J | 1 |
| Ishizone, S | 1 |
| Ikeyama, M | 1 |
| Nakayama, J | 1 |
| Kabashima, A | 2 |
| Sanefuji, K | 2 |
| Maekawa, S | 2 |
| Naito, M | 1 |
| Chino, S | 1 |
| Ushiku, H | 1 |
| Nishi, Y | 1 |
| Kondo, Y | 2 |
| Kubo, H | 2 |
| Kaida, T | 1 |
| Yamashita, W | 1 |
| Takahashi, Y | 1 |
| Watanabe, M | 1 |
| Tsukamoto, T | 2 |
| Takahama, M | 1 |
| Kodai, S | 1 |
| Kanazawa, A | 2 |
| Hori, T | 2 |
| Kaizaki, R | 1 |
| Takatsuka, S | 1 |
| Komatsu, R | 1 |
| Shimomura, K | 1 |
| Furuke, Y | 1 |
| Tanaka, Y | 5 |
| Kumano, T | 1 |
| Komatsu, S | 1 |
| Imura, K | 1 |
| Ikeda, J | 1 |
| Taniguchi, F | 1 |
| Shioaki, Y | 1 |
| Nakatsugawa, Y | 1 |
| Enomoto, T | 2 |
| Mikami, S | 1 |
| Kitajima, M | 1 |
| Hiwatari, M | 1 |
| Ono, T | 1 |
| Sasaki, N | 1 |
| Saji, O | 2 |
| Matsushita, T | 1 |
| Kobayashi, S | 5 |
| Koizumi, S | 2 |
| Ariizumi, Y | 1 |
| Nakajima, T | 2 |
| Otsubo, T | 2 |
| Okamoto, S | 1 |
| Cho, H | 2 |
| Morino, K | 1 |
| Seo, S | 1 |
| Yoh, T | 1 |
| Nishino, H | 2 |
| Yamanaka, K | 1 |
| Fukumitsu, K | 1 |
| Ishii, T | 1 |
| Taura, K | 1 |
| Okajima, H | 1 |
| Kaido, T | 1 |
| Uemoto, S | 1 |
| Murata, T | 1 |
| Yoshino, H | 1 |
| Kaneko, M | 1 |
| Yamada, T | 2 |
| Horiguchi, J | 1 |
| Takata, D | 1 |
| Rokutanda, N | 1 |
| Nagaoka, R | 1 |
| Tokiniwa, H | 1 |
| Odawara, H | 1 |
| Kikuchi, M | 1 |
| Sato, A | 1 |
| Takeyoshi, I | 1 |
| Yokosuka, T | 1 |
| Kobayashi, T | 2 |
| Takeda, A | 1 |
| Ishida, K | 2 |
| Ishii, M | 1 |
| Kobayashi, H | 1 |
| Sumiyoshi, K | 1 |
| Asano, T | 1 |
| Iwata, K | 1 |
| Okamura, R | 1 |
| Yamaguchi, Y | 1 |
| Nishidoi, H | 1 |
| Shibata, S | 1 |
| Ozaki, Y | 1 |
| Ueta, T | 1 |
| Yamashiro, Y | 1 |
| Ishiguro, M | 1 |
| Kudo, H | 1 |
| Aoyama, T | 2 |
| Hayashi, T | 2 |
| Fujikawa, H | 1 |
| Ogata, T | 1 |
| Wada, H | 3 |
| Kitani, Y | 1 |
| Yukawa, N | 1 |
| Oshima, T | 1 |
| Rino, Y | 1 |
| Ozawa, Y | 1 |
| Masuda, M | 1 |
| Yoshikawa, T | 2 |
| Hasuike, Y | 2 |
| Iwagami, Y | 1 |
| Toyomasu, T | 1 |
| Yoshikawa, S | 1 |
| Hirao, S | 1 |
| Koshino, T | 1 |
| Tomoda, K | 1 |
| Matsui, T | 1 |
| Aoyagi, H | 1 |
| Kaneko, J | 1 |
| Yoshida, T | 2 |
| Hasegawa, K | 2 |
| Isogai, J | 1 |
| Maejima, S | 1 |
| Wada, Y | 1 |
| Okada, K | 5 |
| Ebisui, C | 2 |
| Kato, R | 1 |
| Makino, S | 1 |
| Takeoka, T | 1 |
| Yanagisawa, T | 2 |
| Okamura, S | 2 |
| Fukuchi, N | 2 |
| Murata, K | 2 |
| Yokouchi, H | 2 |
| Kinuta, M | 2 |
| Nishikawa, K | 3 |
| Iwase, K | 1 |
| Aono, T | 1 |
| Yoshida, H | 2 |
| Nomura, M | 2 |
| Tamagawa, H | 1 |
| Matsuda, C | 1 |
| Deguchi, T | 1 |
| Kawada, J | 2 |
| Higashi, S | 1 |
| Deguchi, K | 1 |
| Noguchi, Y | 1 |
| Okumura, Y | 1 |
| Fushimi, H | 1 |
| Takagi, M | 1 |
| Fukui, A | 1 |
| Fujitani, K | 2 |
| Endo, S | 1 |
| Dong, L | 1 |
| Li, J | 1 |
| Lou, XP | 1 |
| Miao, JH | 1 |
| Lu, P | 1 |
| Chang, ZW | 1 |
| Han, ZF | 1 |
| Aoe, K | 1 |
| Takigawa, N | 1 |
| Hotta, K | 1 |
| Maeda, T | 1 |
| Kishino, D | 1 |
| Nogami, N | 1 |
| Tabata, M | 1 |
| Harita, S | 1 |
| Okada, T | 1 |
| Kubo, T | 1 |
| Hosokawa, S | 1 |
| Fujiwara, K | 1 |
| Gemba, K | 1 |
| Yasugi, M | 1 |
| Kozuki, T | 1 |
| Kato, Y | 1 |
| Katsui, K | 1 |
| Kanazawa, S | 1 |
| Ueoka, H | 1 |
| Tanimoto, M | 1 |
| Kiura, K | 1 |
| Maeda, H | 1 |
| Okamoto, K | 1 |
| Sakamoto, J | 1 |
| Usui, T | 1 |
| Kawamura, A | 1 |
| Tamura, S | 2 |
| Takeshita, A | 1 |
| Kobayashi, M | 1 |
| Fujisaki, S | 1 |
| Takashina, M | 1 |
| Tomita, R | 1 |
| Sakurai, K | 3 |
| Takayama, T | 1 |
| Ueta, A | 1 |
| Toyama, H | 1 |
| Goto, T | 1 |
| Matsumoto, I | 2 |
| Shinzeki, M | 1 |
| Asari, S | 1 |
| Ishida, J | 1 |
| Nanno, Y | 1 |
| Tsugawa, D | 1 |
| Kuramitsu, K | 1 |
| Tanaka, M | 1 |
| Takebe, A | 1 |
| Okazaki, T | 1 |
| Kido, M | 1 |
| Ajiki, T | 2 |
| Okuno, T | 1 |
| Kokubun, M | 1 |
| Ito, T | 2 |
| Ku, Y | 2 |
| Oka, Y | 1 |
| Uemura, H | 1 |
| Omura, Y | 1 |
| Miyake, Y | 2 |
| Nakane, S | 1 |
| Higaki, N | 1 |
| Hayashida, H | 1 |
| Nezu, R | 1 |
| Natsume, S | 1 |
| Iwasaki, Y | 2 |
| Yajima, K | 1 |
| Yuu, K | 1 |
| Oohinata, R | 2 |
| Ishiyama, S | 1 |
| Takahashi, K | 3 |
| Maeda, Y | 1 |
| Nushijima, Y | 1 |
| Mihara, K | 1 |
| Yamashiro, N | 1 |
| Nishiya, S | 1 |
| Kemmochi, T | 1 |
| Ito, Y | 2 |
| Egawa, T | 2 |
| Nagashima, A | 1 |
| Fukuda, Y | 1 |
| Kanzawa, M | 1 |
| Yamamoto, K | 2 |
| Hirao, M | 3 |
| Harada, Y | 1 |
| Maeda, S | 2 |
| Haraguchi, N | 1 |
| Miyake, M | 2 |
| Asaoka, T | 1 |
| Omiya, H | 1 |
| Miyamoto, A | 2 |
| Ikeda, M | 2 |
| Takami, K | 1 |
| Kodama, Y | 1 |
| Mano, M | 1 |
| Nakamori, S | 2 |
| Sekimoto, M | 2 |
| Higuchi, I | 1 |
| Akiyama, Y | 1 |
| Yamamoto, M | 3 |
| Tanigawa, T | 1 |
| Miyamoto, M | 1 |
| Ogasawara, T | 2 |
| Ootsuka, Y | 1 |
| Nakano, S | 1 |
| Shida, T | 1 |
| Nomura, S | 1 |
| Kin, M | 1 |
| Takahashi, M | 2 |
| Komatsu, T | 1 |
| Iwai, N | 1 |
| Wakabayashi, N | 1 |
| Matsumoto, N | 1 |
| Morita, Y | 1 |
| Tanaka, N | 1 |
| Yoriki, H | 1 |
| Fujii, K | 1 |
| Takada, R | 1 |
| Takaya, H | 1 |
| Masuzawa, A | 1 |
| Takami, S | 1 |
| Kataoka, K | 1 |
| Miki, A | 1 |
| Hirose, T | 2 |
| Minami, T | 1 |
| Morioka, H | 1 |
| Suzuki, T | 4 |
| Otani, T | 2 |
| Kitamura, K | 1 |
| Yoshitani, S | 1 |
| Ishikawa, Y | 1 |
| Nishihira, T | 1 |
| Aoki, S | 1 |
| Mizuma, M | 1 |
| Oyauchi, M | 1 |
| Okada, R | 1 |
| Abe, T | 1 |
| Sakata, N | 2 |
| Nakagawa, K | 1 |
| Hayashi, H | 2 |
| Morikawa, T | 1 |
| Motoi, F | 1 |
| Naitoh, T | 1 |
| Okada, Y | 1 |
| Unno, M | 1 |
| Yamamichi, K | 1 |
| Sueyoshi, H | 1 |
| Sakaguchi, T | 1 |
| Hishikawa, H | 1 |
| Ueda, A | 1 |
| Matsuura, T | 1 |
| Ozaki, T | 1 |
| Saito, T | 3 |
| Omori, K | 1 |
| Wakabayashi, K | 1 |
| Suematsu, Y | 1 |
| Suda, H | 1 |
| Hiratsuka, M | 1 |
| Saito, H | 1 |
| Ishibashi, Y | 1 |
| Morita, A | 1 |
| Kimura, Y | 3 |
| Makari, Y | 3 |
| Mikami, J | 2 |
| Kawase, T | 2 |
| Hamakawa, T | 2 |
| Hoshino, H | 1 |
| Nakata, K | 2 |
| Yamamoto, T | 1 |
| Yamamura, J | 1 |
| Kamigaki, S | 2 |
| Ikeda, N | 1 |
| Tsujie, M | 2 |
| Munakata, S | 1 |
| Ohzato, H | 2 |
| Tomita, Y | 1 |
| Fujii, Y | 1 |
| Miura, S | 1 |
| Fujita, J | 2 |
| Morioka, E | 1 |
| Kaida, D | 1 |
| Ohonishi, T | 1 |
| Ohono, Y | 1 |
| Noguchi, M | 1 |
| Funaki, H | 1 |
| Fujita, H | 1 |
| Kinami, S | 1 |
| Nakano, Y | 3 |
| Ueda, N | 1 |
| Kosaka, T | 1 |
| Kim, Y | 1 |
| Hosoda, Y | 1 |
| Nishino, M | 1 |
| Okano, M | 1 |
| Yamasaki, M | 2 |
| Nagai, K | 2 |
| Yasui, M | 1 |
| Okuyama, M | 1 |
| Tsujinaka, T | 2 |
| Ebihara, K | 1 |
| Kato, F | 1 |
| Tsukamoto, Y | 1 |
| Fujimori, M | 1 |
| Gobaru, A | 1 |
| Mitsudo, D | 1 |
| Yabuta, T | 1 |
| Kitamura, S | 1 |
| Okamoto, T | 1 |
| Tanaka, K | 2 |
| Yonemitsu, K | 1 |
| Munechika, T | 1 |
| Nomi, M | 1 |
| Maeno, H | 1 |
| Nagao, S | 1 |
| Kawamoto, S | 1 |
| Sasaguri, T | 1 |
| Sueishi, K | 1 |
| Miyazawa, K | 1 |
| Yoshioka, S | 1 |
| Shiobara, M | 1 |
| Wakatsuki, K | 1 |
| Kataoka, M | 1 |
| Arai, S | 1 |
| Suda, K | 1 |
| Oeda, Y | 1 |
| Takagi, T | 1 |
| Eto, R | 1 |
| Nakatsu, H | 1 |
| Ozasa, H | 1 |
| Shimizu, R | 1 |
| Okuma, Y | 1 |
| Hosomi, Y | 1 |
| Miyamoto, S | 1 |
| Shibuya, M | 1 |
| Okamura, T | 1 |
| Hishima, T | 1 |
| Kusama, T | 1 |
| Yamagami, K | 1 |
| Hasegawa, M | 1 |
| Sone, N | 1 |
| Kokado, Y | 1 |
| Koshiba, T | 1 |
| Ichikawa, K | 1 |
| Miyata, R | 1 |
| Kameyama, N | 1 |
| Tomita, M | 1 |
| Mitsuhashi, H | 1 |
| Baba, S | 1 |
| Amada, E | 1 |
| Yamauchi, K | 1 |
| Kokuryo, T | 1 |
| Yokoyama, Y | 1 |
| Uehara, K | 1 |
| Yamaguchi, J | 1 |
| Nagino, M | 1 |
| Anan, T | 1 |
| Okuma, M | 1 |
| Ichihara, K | 1 |
| Hasegawa, T | 1 |
| Yoshida, K | 1 |
| Yanaga, K | 1 |
| Tsuruda, Y | 1 |
| Ishigami, S | 1 |
| Uenosono, Y | 1 |
| Yanagita, S | 1 |
| Matsushita, D | 1 |
| Arigami, T | 1 |
| Uchikado, Y | 1 |
| Kita, Y | 1 |
| Baba, K | 1 |
| Mori, S | 1 |
| Okumura, H | 1 |
| Maemura, K | 1 |
| Natsugoe, S | 1 |
| Tanaka, S | 3 |
| Nagase, S | 1 |
| Iyoda, T | 1 |
| Kanno, H | 1 |
| Akase, T | 1 |
| Arakawa, I | 1 |
| Inoue, T | 1 |
| Uetsuka, Y | 1 |
| Fujita, S | 2 |
| Ohki, S | 1 |
| Kase, K | 1 |
| Yamauchi, N | 1 |
| Chida, S | 1 |
| Hayase, S | 1 |
| Sakamoto, W | 1 |
| Monma, T | 1 |
| Takawa, M | 1 |
| Ohtake, T | 1 |
| Kono, K | 1 |
| Takenoshita, S | 1 |
| Usui, K | 1 |
| Hanyu, T | 1 |
| Ichikawa, H | 1 |
| Ishikawa, T | 1 |
| Muneoka, Y | 1 |
| Sato, Y | 1 |
| Kano, Y | 1 |
| Hishiki, M | 1 |
| Nagahashi, M | 1 |
| Sakata, J | 1 |
| Kameyama, H | 1 |
| Kosugi, S | 1 |
| Wakai, T | 1 |
| Hama, N | 1 |
| Uemura, M | 1 |
| Miyake, K | 1 |
| Miyazaki, M | 2 |
| Takata, M | 1 |
| Saito, D | 1 |
| Yoshida, S | 1 |
| Kakegawa, S | 1 |
| Tamura, M | 1 |
| Takemura, H | 1 |
| Ikeda, H | 2 |
| Morimoto, S | 1 |
| Tsuji, T | 1 |
| Shono, Y | 1 |
| Akiyama, I | 1 |
| Fujita, Y | 1 |
| Tabuse, K | 1 |
| Matsusaki, K | 1 |
| Hirose, N | 1 |
| Morita, M | 1 |
| Okamoto, F | 1 |
| Kawano, T | 2 |
| Miura, O | 1 |
| Okazaki, Y | 1 |
| Toda, T | 1 |
| Minamisono, Y | 1 |
| Nagasaki, S | 1 |
| Oh, SY | 1 |
| Lee, GW | 1 |
| Kim, HG | 1 |
| Kim, TH | 1 |
| Kim, HJ | 2 |
| Kang, JH | 1 |
| Tokairin, Y | 1 |
| Iida, M | 1 |
| Yamazaki, S | 1 |
| Yoshino, S | 1 |
| Oka, M | 1 |
| Kurokawa, T | 1 |
| Arita, K | 1 |
| Kuramochi, J | 1 |
| Usui, S | 1 |
| Matsumoto, A | 1 |
| Takiguchi, N | 1 |
| Hiranuma, S | 1 |
| Sanada, K | 1 |
| Sugimoto, N | 1 |
| Narahara, H | 1 |
| Sakai, D | 1 |
| Yamamoto, S | 1 |
| Fumoto, S | 1 |
| Yagi, T | 1 |
| Imamura, F | 2 |
| Iishi, H | 1 |
| Tatsuta, M | 1 |
| Yano, H | 1 |
| Iwazawa, T | 2 |
| Miyazaki, S | 2 |
| Danno, K | 1 |
| Kano, T | 1 |
| Ohnishi, T | 1 |
| Tono, T | 1 |
| Monden, T | 1 |
| Imaoka, S | 1 |
| Sunaga, T | 1 |
| Suzuki, S | 1 |
| Harada, N | 1 |
| Suzuki, M | 1 |
| Hata, A | 1 |
| Nanjo, S | 1 |
| Otsuka, K | 1 |
| Kida, Y | 1 |
| Higashi, Y | 1 |
| Kaji, R | 1 |
| Katakami, N | 1 |
| Sugawara, H | 1 |
| Ichiki, M | 1 |
| Sai, K | 1 |
| Kamata, K | 1 |
| Ansai, M | 1 |
| Kawamura, M | 1 |
| Ichinose, A | 1 |
| Tsutani, Y | 1 |
| Ohara, M | 1 |
| Minami, K | 1 |
| Miyahara, E | 1 |
| Kameda, A | 1 |
| Noso, Y | 1 |
| Kim, HS | 1 |
| Park, MJ | 1 |
| Uhm, JE | 1 |
| Lee, Y | 1 |
| Lee, HY | 1 |
| Kang, EM | 1 |
| Lee, J | 1 |
| Park, SH | 1 |
| Park, JO | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Park, YS | 1 |
| Yokoyama, T | 1 |
| Tokuhara, H | 1 |
| Hashimoto, O | 1 |
| Seki, H | 1 |
| Koyanagi, K | 1 |
| Bessho, T | 1 |
| Takakuwa, O | 1 |
| Oguri, T | 1 |
| Sato, S | 1 |
| Nakao, M | 1 |
| Ohta, C | 1 |
| Iwashima, Y | 1 |
| Maeno, K | 1 |
| Kutsuna, T | 1 |
| Nakamura, A | 1 |
| Ueda, R | 1 |
| Ueda, S | 1 |
| Minami, Y | 1 |
| Hara, Y | 1 |
| Maekawa, K | 1 |
| Fukada, I | 1 |
| Yamaguchi, K | 1 |
| Okabe, M | 1 |
| Tsuruta, A | 1 |
| Morimoto, Y | 1 |
| Kawamoto, K | 2 |
| Sano, K | 1 |
| Paku, T | 1 |
| Imai, S | 1 |
| Yoshida, Y | 1 |
| Ogasahara, K | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Asada, T | 1 |
| Takaya, T | 1 |
| Shimayama, T | 1 |
| Imada, S | 1 |
| Futami, S | 1 |
| Hidaka, H | 1 |
| Chijiiwa, K | 1 |
| Teshima, S | 1 |
| Endo, A | 1 |
| Yunome, G | 1 |
| Harada, A | 1 |
| Ooshio, H | 1 |
| Kodama, H | 1 |
| Takeda, K | 1 |
| Kikuchi, S | 1 |
| Tokunaga, Y | 1 |
| Sasaki, H | 1 |
| Hashimoto, M | 1 |
| Moriyuki, T | 1 |
| Kuranishi, F | 1 |
| Niitsu, H | 1 |
| Fujikuni, N | 1 |
| Iwako, H | 1 |
| Kuroda, Y | 1 |
| Sakaguchi, H | 1 |
| Aizawa, K | 1 |
| Muramatsu, S | 1 |
| Matsushita, A | 1 |
| Kumaki, T | 1 |
| Kasuga, Y | 1 |
| Kijima, D | 1 |
| Tada, K | 1 |
| Miyahara, M | 1 |
| Hasegawa, H | 2 |
| Arai, T | 1 |
| Miwa, H | 1 |
| Fukunaga, M | 1 |
| Ohsato, H | 1 |
| Imamura, H | 1 |
| Sohta, Y | 1 |
| Kaze, C | 1 |
| Furukawa, H | 1 |
| Sugishita, H | 1 |
| Ishida, N | 1 |
| Yoshida, M | 1 |
| Sato, K | 1 |
| Doi, T | 2 |
| Horiuchi, A | 1 |
| Watanabe, Y | 1 |
| Wakahara, T | 1 |
| Toyokawa, A | 1 |
| Tomono, A | 1 |
| Tani, S | 1 |
| Yamamichi, T | 1 |
| Nishioka, N | 1 |
| Gon, H | 1 |
| Yamashita, H | 1 |
| Kanemitsu, K | 1 |
| Takahashi, T | 2 |
| Okuda, T | 1 |
| Hamabe, Y | 1 |
| Iwasaki, T | 1 |
| Ishida, T | 1 |
| Fujita, T | 1 |
| Nakamoto, Y | 1 |
| Ogata, M | 1 |
| Fujii, M | 1 |
| Sato, H | 1 |
| Ando, T | 1 |
| Tsujii, S | 1 |
| Nagahori, J | 1 |
| Komatsu, Y | 1 |
| Matsuoka, A | 1 |
| Kurokawa, Y | 2 |
| Nakazuru, S | 1 |
| Mita, E | 1 |
| Shiroyama, T | 1 |
| Komuta, K | 1 |
| Hirashima, T | 1 |
| Kijima, T | 1 |
| Tachibana, I | 1 |
| Kawase, I | 1 |
| Katsumata, N | 1 |
| Hirai, Y | 1 |
| Kamiura, S | 1 |
| Sugiyama, T | 2 |
| Kokawa, K | 1 |
| Hatae, M | 1 |
| Nishimura, R | 1 |
| Ochiai, K | 1 |
| Miyanaga, K | 1 |
| Tabo, T | 1 |
| Ueno, M | 1 |
| Ohkawa, S | 1 |
| Kameda, R | 1 |
| Miyakawa, K | 1 |
| Yamamoto, N | 1 |
| Morinaga, S | 1 |
| Takebayashi, K | 1 |
| Kawai, Y | 1 |
| Tagi, T | 1 |
| Matsumura, M | 1 |
| Shimizu, K | 1 |
| Yamamoto, H | 1 |
| Hirota, N | 1 |
| Tani, T | 1 |
| Sato, M | 1 |
| Nakajima, F | 1 |
| Matsuoka, K | 1 |
| Ogawa, T | 1 |
| Nomura, H | 1 |
| Araya, J | 1 |
| Tezuka, K | 1 |
| Dan, N | 1 |
| Tendo, M | 1 |
| Nakamura, M | 1 |
| Koga, M | 1 |
| Aoki, M | 1 |
| Iwamoto, O | 1 |
| Koga, C | 1 |
| Kusukawa, J | 1 |
| Tsuburaya, A | 1 |
| Saze, Z | 1 |
| Hasegawa, S | 1 |
| Kanemoto, A | 1 |
| Terashima, M | 2 |
| Tahara, H | 1 |
| Kitasato, Y | 1 |
| Yasunaga, M | 1 |
| Nakayama, M | 1 |
| Akasu, G | 1 |
| Yoshitomi, M | 1 |
| Mikagi, K | 1 |
| Kawahara, R | 1 |
| Ishikawa, H | 1 |
| Hisaka, T | 1 |
| Horiuchi, H | 1 |
| Kinoshita, H | 1 |
| Okabe, Y | 1 |
| Fujiwara, Y | 1 |
| Miyata, H | 1 |
| Nakajima, K | 1 |
| Takiguchi, S | 1 |
| Mori, M | 3 |
| Doki, Y | 3 |
| Makino, H | 2 |
| Kametaka, H | 2 |
| Koyama, T | 2 |
| Seike, K | 2 |
| Shimizu, J | 1 |
| Dono, K | 1 |
| Hata, T | 1 |
| Kawanishi, K | 1 |
| Ikeda, K | 1 |
| Akagi, K | 1 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Katsura, Y | 1 |
| Marubashi, S | 2 |
| Eguchi, H | 2 |
| Tanemura, M | 2 |
| Umeshita, K | 2 |
| Wakasa, K | 1 |
| Nagano, H | 2 |
| Nakamura, T | 1 |
| Ota, M | 1 |
| Narumiya, K | 1 |
| Sato, T | 1 |
| Shirai, Y | 1 |
| Kuramochi, H | 1 |
| Hayashi, K | 1 |
| Minamoto, K | 1 |
| Yuasa, I | 1 |
| Ikeda, T | 1 |
| Takeuchi, M | 1 |
| Ogata, Y | 1 |
| Ishibashi, N | 1 |
| Uchida, S | 1 |
| Murakami, N | 1 |
| Kibe, S | 1 |
| Yahara, T | 1 |
| Shirouzu, K | 1 |
| Kimura, M | 1 |
| Usami, E | 1 |
| Ito, D | 1 |
| Iwai, M | 1 |
| Nakao, T | 1 |
| Yoshimura, T | 1 |
| Yasuda, T | 1 |
| Kobayashi, Y | 1 |
| Kadoya, T | 1 |
| Kanno, E | 1 |
| Sasada, T | 1 |
| Kajitani, K | 1 |
| Emi, A | 1 |
| Shigematsu, H | 1 |
| Masumoto, N | 1 |
| Haruta, R | 1 |
| Kataoka, T | 1 |
| Arihiro, K | 1 |
| Okada, M | 1 |
| Goto, A | 1 |
| Itoh, M | 1 |
| Wakasugi, H | 1 |
| Kanno, S | 1 |
| Yabana, T | 1 |
| Mitsuhashi, K | 1 |
| Adachi, T | 1 |
| Shinomura, Y | 1 |
| Takii, M | 1 |
| Kuroda, K | 1 |
| Asano, Y | 1 |
| Kubo, N | 2 |
| Noda, E | 2 |
| Yamada, N | 1 |
| Maeda, K | 2 |
| Sawada, T | 1 |
| Oohashi, M | 1 |
| Iwanaga, T | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, H | 1 |
| Nakano, D | 1 |
| Makuuchi, R | 1 |
| Bando, E | 1 |
| Goto, H | 1 |
| Miki, Y | 1 |
| Yamakawa, Y | 1 |
| Sugisawa, N | 1 |
| Tokunaga, M | 1 |
| Tanizawa, Y | 1 |
| Kawamura, T | 1 |
| Uesaka, K | 1 |
| Yasutomo, N | 1 |
| Kawabata, M | 1 |
| Seike, J | 1 |
| Honda, J | 1 |
| Miyoshi, T | 1 |
| Umemoto, A | 1 |
| Tangoku, A | 1 |
| Handa, R | 1 |
| Iijima, S | 1 |
| Oshima, K | 1 |
| Hoshi, M | 1 |
| Oshima, S | 1 |
| Kato, T | 1 |
| Kurokawa, E | 1 |
| Kikkawa, N | 1 |
| Hosaka, T | 1 |
| Nakashima, M | 1 |
| Ishida, H | 1 |
| Yamaoka, T | 1 |
| Okuda, K | 1 |
| Adachi, M | 1 |
| Zang, DY | 1 |
| Yang, DH | 1 |
| Lee, HW | 1 |
| Hwang, SW | 1 |
| Song, HH | 1 |
| Jung, JY | 1 |
| Kwon, JH | 1 |
| Kim, JH | 2 |
| Park, SR | 1 |
| Kim, MJ | 1 |
| Jang, KM | 1 |
| Park, CK | 1 |
| Lee, BH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase II Study of Oxaliplatin and S-1 (SOX) Versus Oxaliplatin and Capecitabine (XELOX) in Patients With Peritoneal Metastasis of Colorectal Cancer[NCT02870153] | Phase 2 | 60 participants (Anticipated) | Interventional | 2013-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for oxonic acid and Recrudescence
| Article | Year |
|---|---|
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
[A Case of QOL Improvement after Intestinal Stenosis Due to Peritoneal Dissemination of Gastric Cancer in Elderly Patients].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Fe | 2017 |
[An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphati | 2016 |
[Locally recurrent case of gastric cancer with serosal invasion after four months of endoscopic submucosal dissection].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Endos | 2012 |
12 trials available for oxonic acid and Recrudescence
| Article | Year |
|---|---|
[Phase I study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dru | 2013 |
Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docet | 2014 |
A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; | 2014 |
Initial Report of Phase II Study on Bi-weekly SOX plus Cetuximab Treatment for Wild-type K-RAS Advanced and Recurrent Colorectal Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colorectal Neoplasms; Drug C | 2016 |
Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Disease Progression; | 2008 |
[Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Immunotherapy; Lentinan; | 2008 |
[The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male | 2009 |
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2009 |
Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Surviv | 2011 |
Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Human | 2011 |
[Randomized phase II trial to compare S-1 and S-1/PSK for advanced or recurrent gastric cancer-lessons from the results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male | 2011 |
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; H | 2009 |
103 other studies available for oxonic acid and Recrudescence
| Article | Year |
|---|---|
[Evaluation of Prognostic Factors in Patients with Relapse and Unresectable Biliary Tract Cancer, Treated with S-1 after Failure of Gemcitabine].
Topics: Biliary Tract Neoplasms; Deoxycytidine; Gemcitabine; Humans; Oxonic Acid; Prognosis; Pyridines; Recu | 2022 |
Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Topics: Aged; Antineoplastic Agents, Immunological; Drug Combinations; Female; Humans; Nivolumab; Oxonic Aci | 2021 |
[Clinical Experience of S-1 and Oxaliplatin(SOX)as the First-Line Chemotherapy for Metastatic/Recurrent Gastric Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male | 2017 |
Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Drug Combinati | 2017 |
[Chemoradiotherapy with S-1 for Recurrence Cases of Colorectal Cancer].
Topics: Antimetabolites, Antineoplastic; Chemoradiotherapy; Colorectal Neoplasms; Disease Progression; Drug | 2018 |
[Long-Term Survival after Multidisciplinary Treatment for Resected Pancreatic Adenocarcinoma with Recurrence of Pulmonary Metastases - A Case Report].
Topics: Adenocarcinoma; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2017 |
[A Case in Which S-1 plus CDDP and S-1 Therapy Responded to Liver Metastasis Recurrence after Gastric Cancer Operation].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Com | 2018 |
[A Case of P0CY1 Gastric Cancer without Recurrence for 13 Years Postoperatively].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2018 |
The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biliary Tract Surgical Pr | 2019 |
[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphona | 2013 |
[A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy hospital)].
Topics: Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Combinations; Hum | 2013 |
[A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 2013 |
[A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Female; Human | 2013 |
[A case report of recurrent small bowel adenocarcinoma successfully treated with monoclonal antibody against EGFR and S-1].
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Drug | 2013 |
[Clinical significance of the human epidermal growth factor receptor 2( HER2) in patients with recurrent gastric cancer who received S-1 adjuvant chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combin | 2013 |
[Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2013 |
[An effective treatment by chemotherapy with CDDP+CPT-11 for recurrent gastric cancer which S-1 cannot be used owing to adverse effects].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Contraindications; Drug Com | 2013 |
[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2013 |
[A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Resistance, Neopl | 2013 |
[A case of recurrent gastric cancer successfully treated with S-1 oral administration].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Femal | 2015 |
[Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Drug Com | 2014 |
[A case of adjuvant surgery for a patient with initially unresectable locally advanced pancreatic cancer (LAPC) with a favorable response to S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Male; Middle Aged; Oxonic Acid; Pancreat | 2014 |
[A case of surgery for stenosis of the colon from recurrent gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; | 2014 |
[Effectiveness of chemoradiotherapy for a patient with local recurrence of advanced gastric cancer followed by curable gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Eso | 2014 |
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Ad | 2014 |
[A case of resection margin involvement gastric carcinoma that relapsed late after additional gastrectomy].
Topics: Abdominal Abscess; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; D | 2014 |
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combin | 2014 |
[A case of recurrent gastric cancer successfully treated with TS-1+CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
[A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Drug Combinations; Female; Gastrectom | 2015 |
[Six-year survival with recurrent intrahepatic cholangiocarcinoma achieved by simple S-1 administration].
Topics: Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocel | 2015 |
[A Patient with Three-Year Relapse-Free Survival after Surgical Resection for Lung and Liver Metastases of Cholangiocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidi | 2015 |
[A Case of Local Recurrence of Bile Duct Cancer Completely Responding to Chemoradiotherapy with S-1].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Chemoradiotherapy; Drug Com | 2015 |
[A Case of Gemcitabine Refractory Lung Metastasis after Distal Pancreatectomy for Pancreatic Cancer, Effectively Treated with S -1 as Second Line Chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Gemcitabine; Huma | 2015 |
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Female | 2015 |
[A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neo | 2015 |
[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2015 |
[A Case of Rectal Stenosis For Gastric Cancer Recurrence Effectively Treated with a Colonic Stent].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Fatal Outcome; G | 2015 |
[A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2015 |
[A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 2015 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Disease Pro | 2016 |
[Adjuvant Systemic Chemotherapy with S-1/Oxaliplatin or mFOLFOX6 after Curative Resection of Distant Metastases in Patients with Colorectal Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Dru | 2016 |
Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Combination | 2016 |
[A Case of Recurred Gastric Cancer of the Anastomosis Completely Responding to Docetaxel, Cisplatin, and S-1 Triplet Therapy].
Topics: Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Co | 2016 |
[A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; | 2016 |
[Comparison of the Cost-Effectiveness of the SOX and COX Regimens in Patients with Unresectable Advanced and Recurrent Colorectal Cancer Using a Clinical Decision Analysis Approach].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Cost-Benefit | 2016 |
[A Case of Port Site Recurrence after Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gas | 2016 |
[A Case of Advanced Gastric Cancer with Portosystemic Shunt Successfully Treated with Percutaneous Transvenous Coil Embolization].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Embolization, Therapeu | 2016 |
[A Case of Lymph Node Metastasis of Intrahepatic Bile Duct Cancer Successfully Treated Using Multidisciplinary Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2016 |
[A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Middle Aged; Ova | 2017 |
[Study of a relationship between a change in the urinary uracil value after a S-1 long-term administration and the recurrence of stomach cancer].
Topics: Aged; Drug Combinations; Female; Health; Humans; Male; Middle Aged; Oxonic Acid; Recurrence; Stomach | 2008 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2008 |
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combinations; | 2008 |
[A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Diphospho | 2009 |
[A case of an older adult patient with recurrent gastric cancer successfully treated by low-dose S-1 for a long time].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans | 2009 |
[Risk associated with severe hematological toxicity in patients with advanced or recurrent gastric cancer receiving primary combination chemotherapy of cisplatin and S-1 or cisplatin and irinotecan hydrochloride].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Camptothecin; Cisplatin; Drug Combinati | 2009 |
[Two cases of effective S-1 monotherapy for patients with metastatic adenocarcinoma of the lung after multiple previous chemotherapies].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combin | 2009 |
[Noticeable clinical response to S-1/CDDP combination therapy for Virchow node recurrence after surgery for advanced gastric carcinoma with marked involvement of the esophagus - report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2009 |
Docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Comb | 2009 |
[The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dise | 2009 |
[Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 2009 |
[A case of recurrent rectal cancer with multiple lung metastases successfully treated with S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinatio | 2009 |
[A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinati | 2009 |
[A case of recurrent gastric cancer during adjuvant chemotherapy with S-1, treated by S-1 combination chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, A | 2009 |
[Problems of adjuvant chemotherapy with S-1 for gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2010 |
[Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Dru | 2010 |
[A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; | 2010 |
[A case of recurrence with liver metastasis after total gastrectomy for StageIA gastric carcinoma successfully treated with S-1/CDDP combination followed by S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2010 |
[A case of anthracycline- and taxane-resistant recurrent advanced breast cancer successfully treated with S-1 monotherapy].
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Combinations; Drug Resistanc | 2010 |
[A case of luminal B recurrent breast cancer with liver and lymph node metastases successfully treated with combination therapy of S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
[A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2010 |
[S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Humans; Male; Middle Aged; Oxonic | 2010 |
[A case of recurrent gallbladder cancer with a remarkable tumor response to S-1].
Topics: Aged; Drug Combinations; Fatal Outcome; Gallbladder Neoplasms; Humans; Male; Oxonic Acid; Radiograph | 2010 |
[A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2010 |
[A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Acinar Cell; Cisplatin; Drug Combinations | 2010 |
Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Fre | 2010 |
[A case of recurrent gastric cancer successfully treated with S-1 plus CDDP (divided into small dosages)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Drug Comb | 2011 |
[Retroperitoneal metastasis of hepatocellular carcinoma - a case report].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A case of advanced small intestinal cancer treated with S-1 plus cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Combinations; Fatal Outcome; | 2011 |
[A case of multiple metastases breast cancer controlled using S-1 as third-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
[A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy, Needle; Breast Neoplasms; Clavicle; Combine | 2011 |
[Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combination | 2011 |
[A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Deoxycytidine; Drug Combinat | 2011 |
[Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
Topics: Aged; Anesthesia, Local; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combination | 2011 |
[A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Drug Combinati | 2011 |
[A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy].
Topics: Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; | 2011 |
[A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2011 |
[A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dr | 2011 |
[Docetaxel plus S-1 as a second-line chemotherapy for metastasis or recurrence of esophageal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophagea | 2012 |
[A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Camptothecin; Cisplatin; Drug Comb | 2012 |
[A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2012 |
[Tolerable evaluation for chemotherapy with S-1 plus cisplatin in elderly patients with advanced and recurrent gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatine; | 2012 |
[A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast].
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality | 2012 |
[A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Drug C | 2012 |
[A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens].
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Fatal Outcome; Female; Hepa | 2012 |
[A case of early gastric cancer with cervical lymph nodes recurrence 5 years after a curative resection].
Topics: Biopsy; Combined Modality Therapy; Disseminated Intravascular Coagulation; Drug Combinations; Fatal | 2012 |
[A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemoradiotherapy; Drug Combinations; Esophagogastr | 2012 |
[A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Hepatectomy; Hu | 2013 |
[A complete response using TS-1 in a patient with paramesenteric lymph node recurrence of gastric cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administratio | 2004 |
A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2006 |
[Three successful cases with CPT-11 + CDDP chemotherapy where S-1 failed to respond to recurrent gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cisplatin; Dr | 2007 |
[Two cases with recurrent non-small cell lung cancer successfully treated with cisplatin and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dru | 2008 |